Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Adenocarcinoma (EAC)”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Early research (Phase 1)Looking for participantsNCT06657144
What this trial is testing

CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Coherus Oncology, Inc. 154
Not applicableActive Not RecruitingNCT04295811
What this trial is testing

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC

Who this might be right for
Barrett EsophagusEsophageal AdenocarcinomaBarretts Esophagus With Dysplasia+1 more
Lucid Diagnostics, Inc. 784
Not applicableEnded earlyNCT03385343
What this trial is testing

Staging of Superficial EAC Using VLE

Who this might be right for
Esophageal Cancer
Mayo Clinic 30
Early research (Phase 1)Looking for participantsNCT07359443
What this trial is testing

Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaEsophageal Adenocarcinoma (EAC)Adenocarcinoma - Gastroesophageal Junction (GEJ)
UMC Utrecht 39
Not applicableStudy completedNCT04408105
What this trial is testing

Survey Study on Barrett's Esophagus Screening

Who this might be right for
Gastroesophageal Reflux DiseaseBarrett's EsophagusEsophagus Adenocarcinoma
University of Colorado, Denver 725
Early research (Phase 1)Ended earlyNCT04594811
What this trial is testing

NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
NeoImmuneTech 10
Not applicableStudy completedNCT01393483
What this trial is testing

Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)

Who this might be right for
Esophageal CancerAdenocarcinoma
Memorial Sloan Kettering Cancer Center 371
Not applicableActive Not RecruitingNCT06504615
What this trial is testing

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Who this might be right for
Gastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaEsophageal Adenocarcinoma (EAC)+1 more
Bristol-Myers Squibb 208
Not applicableStudy completedNCT03529968
What this trial is testing

Siewert Type I-II: CT, PET-CT, EUS Sensitivity/Specificity for the Assessment of Lymph Node Metastases

Who this might be right for
Siewert Type I-II Adenocarcinoma of the Esophagus
University of Bologna 101
Large-scale testing (Phase 3)Study completedNCT04210115
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Gastroesophageal Junction Carcinoma (GEJC)Esophageal Adenocarcinoma (EAC)
Merck Sharp & Dohme LLC 703
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006